Myeloma Paper of the Day, July 26th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Study of genetic variants in familial Waldenström’s finds pathogenic/likely pathogenic variants in TREX1 and SAMHD1 (at the interface between innate immune response, genotoxic surveillance, DNA repair), and POT1, RECQL4, PTPN11, PMS2.”
The landscape of rare genetic variants in familial Waldenström macroglobulinemia
Authors: Alexander Pemov, Jung Kim, Wen Luo, Jia Liu, Cole Graham, Kristine Jones, Delphine DeMangel, Neal D. Freedman, Charles Dumontet, Bin Zhu, Mary L. McMaster, Douglas R. Stewart
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
Source: Robert Orlowski/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023